Related Experiment Video
Updated: Jul 7, 2026
10:13
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Pharmacologic neuroprotection: the search continues
1University of Manitoba, Winnipeg, Canada. hgrocott@sbgh.mb.ca
The Journal of Extra-Corporeal Technology
|February 26, 2008
Summary
Researchers are exploring new drugs to prevent brain damage after cardiac surgery. While no specific neuroprotective agents are approved, ongoing trials investigate novel mechanisms and targets to reduce side effects.
Area of Science:
- Neuroscience
- Cardiology
- Pharmacology
Background:
- Cardiac surgery can lead to adverse cerebral consequences.
- Existing drug development focuses on post-ischemia pathways and cardiopulmonary bypass inflammation.
Purpose of the Study:
- To review the historical, current, and future landscape of pharmacologic neuroprotection in cardiac surgery.
Main Methods:
- Literature review of studies on drug targets for neuroprotection.
- Analysis of drug mechanisms and side effect profiles.
Main Results:
- Dozens of drugs targeting various pathways have been investigated.
- No specific neuroprotective agents are currently approved for this indication.
Conclusions:
- Ongoing research explores novel targets and mechanisms for improved neuroprotection.
- Future drug development aims for reduced side effects and enhanced efficacy.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
00:49The Blood-brain Barrier
Overview
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...